Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life.
CONCLUSION: Intraprostatic tumor dose escalation using IB-VMAT or MR-guided HDR boost achieved comparable OAR dosimetry, toxicity and HRQOL outcomes, but higher mean and maximal tumor dose were achieved with the HDR technique. Further follow-up will determine long-term outcomes including disease control.
PMID: 32447033 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Sanmamed N, Lee J, Berlin A, Craig T, Lao B, Rink A, Bayley A, Catton C, Sundaramurthy A, WarrenFoltz, McPartlin A, Ghai S, Gospodarowicz M, Warde P, Ménard C, Chung P Tags: Radiother Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | CT Scan | Gastroenterology | PET Scan | Prostate Cancer | Radiology | Science | Statistics | Study | Toxicology